Erik Skjelbo - Concepedia

Author

Erik Skjelbo

Odense University Hospital

Also Known As

E F Skjelbo, E Skjelbo, E. SKJELBO, E. Skjelbo, Erik Skjelbo

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital University of Southern Denmark University College Lillebaelt Amref Health Africa

About

Erik Skjelbo is an author at Odense University Hospital specializing in medicine, drug discovery, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	642
2	Biochemistry	3	3	603
3	Natural Sciences	1	1	371
4	Geriatrics	1	1	19
5	Metabolism	1	1	25

Erik Skjelbo

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Fluvoxamine is a potent inhibitor of cytochrome P4501A2 Kim Brøsen, Erik Skjelbo, Birgitte Buur Rasmussen, Biochemical Pharmacology Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1993	371
The relationship between paroxetine and the sparteine oxidation polymorphism Søren H. Sindrup, Kim Brøsen, Lars F. Gram, Clinical Pharmacology & Therapeutics Steady StatePharmacological StudyBiochemistrySparteine Oxidation PolymorphismSparteine Oxidation	1992	207
Inhibitors of imipramine metabolism by human liver microsomes. Erik Skjelbo British Journal of Clinical Pharmacology	1992	163
The activation of the biguanide antimalarial proguanil co‐segregates with the mephenytoin oxidation polymorphism‐a panel study. Erik Skjelbo, LF Gram, AM Breckenridge British Journal of Clinical Pharmacology	1991	162
The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine Erik Skjelbo, Kim Brøsen, Jesper Hallas, Clinical Pharmacology & Therapeutics	1991	141
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population Lise Bathum, Erik Skjelbo, Theonest K. Mutabingwa, British Journal of Clinical Pharmacology	1999	70
Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians* Erik Skjelbo, Theonest K. Mutabingwa, Ib Christian Bygbjerg, Clinical Pharmacology & Therapeutics	1996	53
Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark. Erik Skjelbo, Helga Flachs British Journal of Clinical Pharmacology	1993	38
The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study. Erik Skjelbo, L. F. Gram, Kim Brøsen PubMed Pharmacological StudyBiochemistryDesipramine/imipramine RatioMedicinePhysiology	1993	25
PHARMACOGENETICS OF TRICYCLIC AND NOVEL ANTIDEPRESSANTS: RECENT DEVELOPMENTS Kim Brøsen, L. F. Gram, Søren H. Sindrup, Clinical Neuropharmacology Systems PharmacologyTranslational PharmacologyPharmacokinetic ModelingPsychiatryPharmacological Study	1992	20

Page 1